The Latest Breaking News from Nasdaq

BMO Capital initiated coverage of Intellia Therapeutics Inc (NASDAQ:NTLA) with a Market Perform rating and a $54 target price.  The analyst says Intellia's gene-editing platform could potentially deliver transformative therapies.  But challenges around the lack of clarity around an IND approval in the U.S., ongoing CRISPR/Cas9 IP litigations with Editas Medicine Inc (NASDAQ:EDIT), and high patient…

BMO Capital initiated coverage on Beam Therapeutics Inc (NASDAQ:BEAM) with a Market Perform rating and a price target of 41. BMO writes that it appreciates the high potential of Beam's next-generation editing approach, but clinical validation is yet to be established. Preclinical base editing data point to a favorable benefit/risk profile. Also Read: Pfizer, Beam…

Verisk Analytics (NASDAQ:VRSK) has outperformed the market over the past 10 years by 2.09% on an annualized basis producing an average annual return of 12.86%. Currently, Verisk Analytics has a market capitalization of $25.64 billion.

Tesla Inc (NASDAQ: TSLA) was trading about 2% higher on Friday, rebounding slightly from a bearish day on Thursday, which saw the stock slide about 4% in tandem with the general markets.

BMO Capital Markets initiated the coverage on Precision BioSciences Inc (NASDAQ:DTIL) with an Outperform rating and a price target of $7. The analyst said the thesis is based on: The company's proprietary gene-editing platform, whose mechanism is differentiated in a CRISPR-dominated space, offers several advantages. A diversified pipeline. Asymmetric risk/reward skewed to the upside.…

The "Game of Thrones" franchise will live on with a highly anticipated sequel series — just the latest in a string of spinoff programming inspired by the popular HBO show that spanned eight seasons.

Needham hailed KLA Corp's (NASDAQ: KLAC) 2022 Investor Day in NYC in a note titled "Investor Day Reveals New 2026 Model Targeting Revenue of $14bn and EPS of $38."

Raymond James hosted an online advertising conference call with an industry expert. The expert has visibility into ~$2 billion of spend with a mix similar to the ad industry and diversified across Fortune 1,000 advertisers. 

Needham's Laura Martin said Meta Platforms Inc's (NASDAQ: META) falling brand value is a lead indicator for rising customer acquisition costs, churn levels, and declining pricing power.